DiaMedica Therapeutics Inc (DMAC) — Tangible Net Worth Ratio
DiaMedica Therapeutics Inc (DMAC) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($47.23 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is DiaMedica Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
DiaMedica Therapeutics Inc Tangible Net Worth Ratio (2005–2025)
This chart shows how DiaMedica Therapeutics Inc's Tangible Net Worth Ratio has changed across 19 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $47.23 Million with intangible assets of $0.00 USD. See operational self-sufficiency of DiaMedica Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for DiaMedica Therapeutics Inc (2005–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for DiaMedica Therapeutics Inc from 2005 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see DMAC market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $56.11 Million | $0.00 | $61.37 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $40.72 Million | $0.00 | $46.34 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $51.06 Million | $0.00 | $54.16 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $31.83 Million | $0.00 | $34.40 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $44.02 Million | $0.00 | $45.55 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $26.01 Million | $0.00 | $28.09 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $7.62 Million | $0.00 | $9.05 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $17.02 Million | $0.00 | $18.34 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $799.00K | $0.00 | $1.80 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $1.25 Million | $0.00 | $1.87 Million | ▲ +19.5 pp |
| 2013 | 80.5% | $1.38 Million | $269.27K | $2.91 Million | ▲ +41.3 pp |
| 2012 | 39.2% | $2.26 Million | $1.38 Million | $3.85 Million | ▼ -0.7 pp |
| 2011 | 39.9% | $5.96 Million | $3.58 Million | $6.33 Million | ▲ +9.4 pp |
| 2010 | 30.5% | $8.52 Million | $5.93 Million | $9.08 Million | ▼ -25.3 pp |
| 2009 | 55.8% | $1.05 Million | $462.99K | $1.25 Million | ▼ -31.4 pp |
| 2008 | 87.2% | $2.78 Million | $356.80K | $3.00 Million | ▲ +0.3 pp |
| 2007 | 86.8% | $4.06 Million | $535.67K | $4.34 Million | ▲ +41.5 pp |
| 2006 | 45.3% | $653.60K | $357.25K | $706.86K | ▼ -9.6 pp |
| 2005 | 54.9% | $506.11K | $228.06K | $562.60K | — |